Beatson, West of Scotland Cancer Centre

Glasgow, Scotland G120YN

3 studies enrolling now · 15 studies all time

What they study most

Advanced Solid Tumors, Advanced Squamous Non-Small Cell Lung Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Hematologic Malignancies, Hepatic Impairment, Inflammatory Breast Cancer Stage IV, Malignant Pleural Mesothelioma, Metastatic Melanoma, Myeloid Leukemia, Chronic, Chronic Phase, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• Clinical Pre-screening Protocol for Ovarian Cancer — Recruiting now
• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors — Recruiting now
• Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma — Completed
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab — Withdrawn before enrolling
• RBN-2397 in Combination With Pembrolizumab in Patients With SCCL — Status unconfirmed
• A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) — Completed
• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC — Stopped early
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer — Completed
• Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors — Stopped early
• A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations — Stopped early
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment — Completed